Moreover, aiming breast cancer cells with IL-6 inhibits proliferation in estrogen receptor (ER) positive cells, however, the main role of IL-6 in breast cancer considers the prognostic use with elevated circulating IL-6 levels being correlated with a poor prognosis in many studies [23]. This evidence concerns the gene ESR1 and breast cancer.